🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Status
Terminated
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Start Date
2003-11
Trial ID
NCT00670410
Treatments Being Tested
The purpose of this study is to determine the safety and feasibility of unr...
Status
Unknown
Location
Hematology-Oncology & SCT Research Center
Start Date
2009-11
Trial ID
NCT01015742
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
University of Florida Health Science Center
Start Date
1998-06
Trial ID
NCT00003661
Acute myeloid leukemia (AML) is a clonal disease caused by genetic mutation...
Status
Unknown
Location
Ruijin Hospital
Start Date
2018-09-01
Trial ID
NCT03913312
Treatments Being Tested
This study is designed to test the ability to achieve donor hematopoietic e...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-11
Trial ID
NCT01626092
RATIONALE: Giving chemotherapy, such as cyclophosphamide and busulfan, and ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
1999-10-06
Trial ID
NCT00612716
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-05-15
Trial ID
NCT02722668
Treatments Being Tested
Background: Severe aplastic anemia (SAA) and myelodysplastic syndrome (MDS...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2017-06-13
Trial ID
NCT03173937
Treatments Being Tested